• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.

作者信息

Murray A M, Waddington J L

机构信息

Department of Clinical Pharmacology, Royal College of Surgeons, Dublin, Ireland.

出版信息

Psychopharmacology (Berl). 1989;98(2):245-50. doi: 10.1007/BF00444699.

DOI:10.1007/BF00444699
PMID:2569218
Abstract

The new, extremely potent and enantioselective D-2 agonist LY 163502 failed to induce compulsive stereotyped behaviour. Very low doses (3-6 micrograms/kg) inhibited spontaneous sniffing and locomotion, while higher doses (12-50 micrograms/kg) induced episodes of non-stereotyped sniffing and chewing; these actions showed complete enantioselectivity. Up to 200-fold higher doses modestly induced only locomotion. Responsivity to LY 163502 was enantioselectively blocked by the selective D-2 antagonist R-piquindone. This responsivity was also enantioselectively blocked by the selective D-1 antagonist R-SK&F 83566 but, additionally, episodes of atypical limb/body jerking behaviour were released; thus, LY 163502 induced such jerking only when tonic D-1 activity was suppressed. These data extend our notion that there may be at least two forms of functional interaction between D-1 and D-2 receptor systems: one cooperative, as in the regulation of typical sniffing, and another oppositional, as in the regulation of atypical jerking.

摘要

相似文献

1
Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.
Psychopharmacology (Berl). 1989;98(2):245-50. doi: 10.1007/BF00444699.
2
The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
Eur J Pharmacol. 1989 Feb 7;160(3):377-84. doi: 10.1016/0014-2999(89)90093-9.
3
Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.对D-1多巴胺激动剂R-SK&F 38393和阿扑吗啡的嗅探、竖毛和运动反应:与选择性D-1和D-2拮抗剂SCH 23390和甲氧氯普胺的差异相互作用。
Eur J Pharmacol. 1985 Feb 5;108(3):305-8. doi: 10.1016/0014-2999(85)90454-6.
4
The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213.
Eur J Pharmacol. 1985 Oct 8;116(1-2):183-6. doi: 10.1016/0014-2999(85)90202-x.
5
Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.D1受体激动剂SKF 38393对阿扑吗啡在大鼠中某些行为效应的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Apr;339(4):383-6. doi: 10.1007/BF00736051.
6
Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.多巴胺 D-1 受体激动剂与选择性 D-2 激动剂喹吡罗联合使用可促进大鼠口腔刻板行为的表达。
Eur J Pharmacol. 1987 Jan 13;133(2):137-45. doi: 10.1016/0014-2999(87)90144-0.
7
New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.新型潜在的多巴胺D-1受体选择性激动剂:CY 208-243与SK&F 101384和SK&F 103243的行为学及神经化学比较
Pharmacol Biochem Behav. 1990 Jan;35(1):105-10. doi: 10.1016/0091-3057(90)90212-z.
8
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.小鼠的攀爬行为和刻板行为需要D-1多巴胺受体的刺激。
Eur J Pharmacol. 1988 Mar 29;148(2):221-9. doi: 10.1016/0014-2999(88)90567-5.
9
The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.氯氮平与多巴胺D1受体介导功能和多巴胺D2受体介导功能之间的相互作用:行为指标
Eur J Pharmacol. 1990 Sep 4;186(1):79-86. doi: 10.1016/0014-2999(90)94062-3.
10
Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.D1激动剂R-SK & F 38393可立体特异性地促进多巴胺能行为,并被D1拮抗剂SCH 23390选择性阻断。
Psychopharmacology (Berl). 1984;82(4):409-10. doi: 10.1007/BF00427697.

引用本文的文献

1
Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.急性给予多巴胺能药物对斑马鱼幼虫的运动有不同的影响。
Pharmacol Biochem Behav. 2013 Feb;103(4):792-813. doi: 10.1016/j.pbb.2012.12.010. Epub 2012 Dec 28.
2
Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior.刺激中枢杏仁核中的多巴胺 D2/D3 受体而非 D1 受体可减少可卡因觅药行为。
Behav Brain Res. 2010 Dec 25;214(2):386-94. doi: 10.1016/j.bbr.2010.06.021. Epub 2010 Jun 19.
3
Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.

本文引用的文献

1
Pharmacological characterization in the rat of grooming and other behavioural responses to the D1 dopamine receptor agonist R-SK&F 38393.在大鼠中对 D1 多巴胺受体激动剂 R-SK&F 38393 的理伦修饰及其他行为反应的药理学特征。
J Psychopharmacol. 1987 Jan;1(3):177-83. doi: 10.1177/026988118700100304.
2
The d-1 dopamine receptor and the search for its functional role: from neurochemistry to behaviour.D1多巴胺受体及其功能作用的探索:从神经化学到行为学
Rev Neurosci. 1987 Apr-Sep;1(3-4):157-84. doi: 10.1515/REVNEURO.1987.1.3-4.157.
3
Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.
新型非典型抗精神病药物奥氮平与ICI 204,636在行为反应方面与氯氮平的比较:对选择性“D1样”多巴胺受体激动剂A 68930和选择性“D2样”激动剂RU 24213的反应
Psychopharmacology (Berl). 1996 Mar;124(1-2):40-9. doi: 10.1007/BF02245604.
4
Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.κ受体激动剂对D1和D2多巴胺激动剂及拮抗剂诱导行为的影响。
Psychopharmacology (Berl). 1996 Jan;123(2):215-21. doi: 10.1007/BF02246181.
5
Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.对先前停用氟哌啶醇治疗的卷尾猴长期给予 D1 受体拮抗剂 SCH 23390 和 D2 受体拮抗剂雷氯必利治疗。锥体外系综合征和多巴胺能超敏反应。
Psychopharmacology (Berl). 1993;112(2-3):389-97. doi: 10.1007/BF02244938.
6
Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.使用新型异色满激动剂A 68930和异喹啉拮抗剂BW 737C对大鼠脑中“D-1样”多巴胺受体亚型的行为学证据。
Psychopharmacology (Berl). 1993;113(1):45-50. doi: 10.1007/BF02244332.
7
The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.氯氮平对选择性“D1样”多巴胺受体激动剂A 68930以及选择性“D2样”激动剂RU 24213行为反应的影响。
Br J Pharmacol. 1994 Nov;113(3):839-44. doi: 10.1111/j.1476-5381.1994.tb17069.x.
8
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.对正常普通狨猴施用选择性 D-1 和 D-2 多巴胺能药物后的运动活动
Psychopharmacology (Berl). 1991;105(3):303-9. doi: 10.1007/BF02244422.
9
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.作用于D-1和D-2多巴胺受体的药物在大鼠中诱发相同的无目的咀嚼行为,这种行为可通过胆碱能操作加以区分。
Psychopharmacology (Berl). 1991;103(4):503-12. doi: 10.1007/BF02244250.
10
Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.
Psychopharmacology (Berl). 1992;106(4):447-54. doi: 10.1007/BF02244813.
D1激动剂R-SK & F 38393可立体特异性地促进多巴胺能行为,并被D1拮抗剂SCH 23390选择性阻断。
Psychopharmacology (Berl). 1984;82(4):409-10. doi: 10.1007/BF00427697.
4
Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.D-1和D-2多巴胺受体在大鼠新纹状体中环磷酸腺苷流出中的相反作用。
Nature. 1981 Nov 26;294(5839):366-8. doi: 10.1038/294366a0.
5
Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.SK&F 83566对映体作为纹状体D-1多巴胺受体特异性和立体选择性拮抗剂的鉴定:与Ro 22-1319的D-2对映体选择性比较。
Eur J Pharmacol. 1984 Oct 30;106(1):219-20. doi: 10.1016/0014-2999(84)90705-2.
6
SCH 23390 - the first selective dopamine D-1 antagonist.SCH 23390——首个选择性多巴胺D-1拮抗剂。
Eur J Pharmacol. 1983 Jul 15;91(1):153-4. doi: 10.1016/0014-2999(83)90381-3.
7
Stimulation of postsynaptic DA2 receptors produces jerks in reserpine-treated rats.刺激突触后DA2受体会使经利血平处理的大鼠产生抽搐。
J Pharm Pharmacol. 1983 Aug;35(8):543-5. doi: 10.1111/j.2042-7158.1983.tb04834.x.
8
SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.SCH 23390,一种可能的苯并氮杂䓬类抗精神病药物,对多巴胺能系统具有独特的相互作用。
J Pharmacol Exp Ther. 1983 Aug;226(2):462-8.
9
Pharmacological effects of Ro 22-1319: a new antipsychotic agent.新型抗精神病药物Ro 22 - 1319的药理作用
Psychopharmacology (Berl). 1983;79(1):32-9. doi: 10.1007/BF00433013.
10
Brain dopamine receptors.脑多巴胺受体
Pharmacol Rev. 1980 Sep;32(3):229-313.